Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease
出版年份 2011 全文链接
标题
Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease
作者
关键词
-
出版物
PLoS One
Volume 6, Issue 9, Pages e23379
出版商
Public Library of Science (PLoS)
发表日期
2011-09-07
DOI
10.1371/journal.pone.0023379
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Noninfectious Pneumonitis after Everolimus Therapy for Advanced Renal Cell Carcinoma
- (2010) Dorothy A. White et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Topical Rapamycin
- (2010) Anna K. Haemel et al. ARCHIVES OF DERMATOLOGY
- Serum Vascular Endothelial Growth Factor-D Prospectively Distinguishes Lymphangioleiomyomatosis From Other Diseases
- (2010) Lisa R. Young et al. CHEST
- Comparison of three rapamycin dosing schedules in A/J Tsc2+/- mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors
- (2010) Chelsey Woodrum et al. Journal of Translational Medicine
- Tsc2-Rheb signaling regulates EphA-mediated axon guidance
- (2010) Duyu Nie et al. NATURE NEUROSCIENCE
- Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis
- (2010) Darcy A. Krueger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated
- (2009) Prasanna Sooriakumaran et al. BJU INTERNATIONAL
- Serum Vascular Endothelial Growth Factor-D Levels in Patients With Lymphangioleiomyomatosis Reflect Lymphatic Involvement
- (2009) Connie G. Glasgow et al. CHEST
- VEGFs and receptors involved in angiogenesis versus lymphangiogenesis
- (2009) Marja Lohela et al. CURRENT OPINION IN CELL BIOLOGY
- Sirolimus and Everolimus Induced Pneumonitis in Adult Renal Allograft Recipients: Experience in a Center
- (2009) A. Rodríguez-Moreno et al. TRANSPLANTATION PROCEEDINGS
- Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models
- (2009) Nancy Lee et al. BMC Pharmacology & Toxicology
- Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex
- (2008) Ling-Hui Zeng et al. ANNALS OF NEUROLOGY
- The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis
- (2008) G.F.L. Hofbauer et al. BRITISH JOURNAL OF DERMATOLOGY
- Developing a national collaborative study system for rare genetic diseases
- (2008) Michael S Watson et al. GENETICS IN MEDICINE
- Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function
- (2008) L. Meikle et al. JOURNAL OF NEUROSCIENCE
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
- Reversal of learning deficits in a Tsc2 +/− mouse model of tuberous sclerosis
- (2008) Dan Ehninger et al. NATURE MEDICINE
- Diagnostic Potential of Serum VEGF-D for Lymphangioleiomyomatosis
- (2008) Lisa R. Young et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
- (2008) John J. Bissler et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started